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Hypertension is a major risk factor for cardiovascular 
events and mortality (1-4). Hypertension occurs in 69% 
of individuals with first myocardial infarction (5), 77% of 
individuals with first stroke (5), 74% of individuals with heart 
failure (5), and 60% of individuals with peripheral arterial 
disease (6). Hypertension has been diagnosed if the systolic 
blood pressure is 140 mmHg or higher or if the diastolic 
blood pressure is 90 mmHg or higher (1-4). However, on the 
basis of data from the Systolic Blood Pressure Intervention 
Trial (SPRINT) (7,8) and a meta-analysis of prospective 
studies showing the impact of baseline prehypertension on 
cardiovascular events and all-cause mortality in the general 
population (9), this author considers hypertension to be 
either a systolic blood pressure of 130 mmHg or higher or a 
diastolic blood pressure of 80 mmHg or higher.
Pseudohypertension is a falsely increased systolic blood 
pressure caused by markedly atherosclerotic arteries which 
do not collapse during inflation of the blood pressure 
cuff (2,10). Pseudohypertension should be suspected in 
older persons with refractory hypertension, no target 
organ damage or cardiovascular disease, and symptoms 
of overmedication (2). Diagnosis of pseudohypertension 
should be confirmed by direct intra-arterial measurement of 
blood pressure (11).
White coat hypertension is diagnosed if a patient not 
receiving antihypertensive medication has a persistently 
high office blood pressure with a normal; ambulatory 
blood pressure or home blood pressure (1-3,12). Masked 
hypertension is diagnosed if the patient has a normal office 
blood pressure measurement but increased ambulatory 
blood pressure monitoring or home blood pressure 
measurements that are consistently increased (13). 
Measurement of blood pressure is very important in the 
diagnosis and treatment of hypertension. This editorial will 
discuss the appropriate measurement of blood pressure.
Hypertension is diagnosed if the blood pressure 
is elevated on at least three different blood pressure 
measurements taken on two or more office visits (1,2). The 
blood pressure should be taken after the patient is sitting 
comfortably for at least 5 minutes, with the back supported, 
feet on the floor, arm supported in the horizontal position 
on a desk or table, with the middle of the blood pressure 
cuff on the patient’s upper arm at the level of the right 
atrium (the midpoint of the sternum) (2,14). The correct 
blood pressure cuff size should be used so that the bladder 
encircles at least 80% of the upper arm circumference (2). 
The blood pressure device should be validated periodically. 
If the blood pressure is being taken with a mercury 
sphygmomanometer, the cuff pressure should be deflated 
2 mmHg per second with the systolic blood pressure 
recorded at the onset of the first Korotkoff sound and the 
diastolic blood pressure recorded when all Korotkoff sounds 
disappear. For manual determination of blood pressure, 
estimate the systolic blood pressure when the radial pulse is 
obliterated and inflate the cuff 20 to 30 mmHg above this 
level for an auscultatory measurement of the blood pressure.
The patient must avoid smoking, drinking a caffeine 
beverage, and exercising for at least 30 minutes before the 
blood pressure is measured. The patient should empty 
his or her urinary bladder before the blood pressure is 
measured. Neither the patient nor the person measuring 
the blood pressure should talk during the procedure. All 
clothing covering the location of cuff placement should be 
removed. 
The blood pressure also should be measured with the 
person standing for 1 to 3 minutes to evaluate for postural 
hypotension or hypertension (2,15,16). Older patients 
should also be evaluated for postprandial hypotension, 
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which is especially common in frail older patients taking 
multiple antihypertensive and psychotropic drugs (2,17). 
During the initial blood pressure visit, the blood pressure 
should be measured in both arms with the arm with the 
highest blood pressure used for future monitoring of the 
blood pressure (2,18).
Measurement of blood pressure by use of a mercury 
sphygmomanometer has given way to use of oscillometric 
devices which use a sensor to detect oscillations in pulsatile 
blood volume during cuff inflation and deflation. Blood 
pressure is indirectly calculated from maximum amplitude 
algorithms using population-based data. Only automated 
devices with a validated measurement protocol should 
be used. The SPRINT trial measured blood pressure 
during office visits with the patient sitting in a quiet room 
after 5 minutes of quiet rest with the use of an automated 
blood pressure measurement system (Model 907, Omron 
Healthcare) (7,8). No other person was in the room during 
blood pressure measurement to avoid the white coat effect. 
Dose adjustment of medications was based on a mean of 
three blood pressure measurements. This method of blood 
pressure measurement is the most accurate. 
Self-monitoring of blood pressure at home is very helpful 
in the diagnosis and management of hypertension (2,19,20). 
At 1-year follow-up of 450 patients with hypertension at 
high risk of cardiovascular disease, compared with a control 
group, self-monitoring of blood pressure with self-titration 
of antihypertensive medication reduced the blood pressure 
8.8/3.1 mmHg (19). 
Ambulatory blood pressure monitoring is a better 
predictor of cardiovascular risk than office blood pressure 
measurements (2,21-23). A meta-analysis of 7,030 persons 
in four populations showed at a median of 9.5 years of 
follow-up that 10 to 20 hours of daytime ambulatory 
blood pressure monitoring predicted cardiovascular events 
better than conventional blood pressure monitoring (22). 
Cardiovascular risk increased from a normal blood pressure 
over white coat and masked hypertension to sustained 
hypertension (22). A meta-analysis of nine cohorts 
including 13,844 patients with hypertension showed that 
9-time systolic blood pressure independently predicted 
cardiovascular events better than clinic systolic blood 
pressure and daytime systolic blood pressure (23). 
The 2016 Canadian Hypertension Education Program 
Guideline from Hypertension Canada recommends 
the use of unattended automated office blood pressure 
measurements with a 5-minute rest period as performed 
in the SPRINT trial (7,8) in addition to home blood 
pressure measurement and ambulatory blood pressure 
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